Dorzolamide in combination with timolol for the treatment of elevated intraocular pressure (IOP) in patients with open angle glaucoma or pseudo-exfoliative glaucoma, when topical beta-blocker monotherapy is not sufficient.

Product characteristics

Active ingredient: Dorzolamide (as hydrochloride) + timolol (as maleate)

Pharmaceutical form / strength: eye dr.sol. (2 + 0,5)% w/v

Packaging: BT x 1 bottle x 5 ml

pdf product presentation